000

DONGWHA PHARM

No trades
See on Supercharts
Market capitalization
‪239.15 B‬KRW
‪27.44 B‬KRW
‪361.11 B‬KRW
‪17.33 M‬
Beta (1Y)
0.68

About DONGWHA PHARM

CEO
Jun-Ha Yoo
Headquarters
Seoul
Employees (FY)
826
Founded
1897
ISIN
KR7000020008
FIGI
BBG000BDH7Q6
Dong Wha Pharm Co., Ltd. engages in the manufacture and sale of pharmaceuticals and medicinal chemicals. Its products include medicines for digestion, skin scars, general cold, gum treatment, high blood pressure, infection, gastrointestinal tract control, and others. The company was founded on September 25, 1897 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 000020 is 8740 KRW — it has increased by 0.34% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange DONGWHA PHARM stocks are traded under the ticker 000020.
DONGWHA PHARM is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
000020 stock is 1.27% volatile and has beta coefficient of 0.68. Check out the list of the most volatile stocks — is DONGWHA PHARM there?
DONGWHA PHARM revenue for the last quarter amounts to ‪84.50 B‬ KRW despite the estimated figure of ‪70.10 B‬ KRW. In the next quarter revenue is expected to reach ‪95.60 B‬ KRW.
Yes, you can track DONGWHA PHARM financials in yearly and quarterly reports right on TradingView.
000020 stock has risen by 4.05% compared to the previous week, the month change is a 9.34% fall, over the last year DONGWHA PHARM has showed a 4.80% increase.
000020 net income for the last quarter is ‪1.47 B‬ KRW, while the quarter before that showed ‪5.92 B‬ KRW of net income which accounts for −75.18% change. Track more DONGWHA PHARM financial stats to get the full picture.
Today DONGWHA PHARM has the market capitalization of ‪241.42 B‬, it has increased by 3.57% over the last week.
Yes, 000020 dividends are paid annually. The last dividend per share was 180.00 KRW. As of today, Dividend Yield (TTM)% is 2.07%. Tracking DONGWHA PHARM dividends might help you take more informed decisions.
DONGWHA PHARM dividend yield was 1.75% in 2023, and payout ratio reached 18.16%. The year before the numbers were 1.94% and 24.44% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 000020 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DONGWHA PHARM stock right from TradingView charts — choose your broker and connect to your account.
000020 reached its all-time high on Aug 11, 2020 with the price of 34450 KRW, and its all-time low was 1200 KRW and was reached on May 18, 2004.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 826.00 employees. See our rating of the largest employees — is DONGWHA PHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DONGWHA PHARM technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DONGWHA PHARM stock shows the sell signal. See more of DONGWHA PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DONGWHA PHARM EBITDA is ‪31.45 B‬ KRW, and current EBITDA margin is 8.80%. See more stats in DONGWHA PHARM financial statements.